SCHEMBL7714916

SCHEMBL7714916

COC(=O)CNC[C@H](O[Si](C)(C)C(C)(C)C)c1cccc(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 4/20 0.40
ADRB2 P07550 3/20 0.40
ADRB1 P08588 3/20 0.40
GLA P06280 1/20 0.40
VEGFA P15692 1/20 0.39
FLT1 P17948 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
EGLN3 Q9H6Z9 1/20 0.39
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
AOC3 Q16853 1/20 0.38
KDM4E B2RXH2 1/20 0.37
WDR5 P61964 1/20 0.36
PNP P00491 1/20 0.36
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714914 1.00 ADRB3 (0.40) ADRB3ADRB2ADRB1GLAVEGFA
SCHEMBL7708906 0.89 ADRB3 (0.39) ADRB3ADRB2ADRB1GLAAOC3
SCHEMBL7708901 0.81 SLC6A2 (0.39) ADRB3ADRB2ADRB1GLASMN1; SMN2
SCHEMBL8586761 0.80 ADRB3 (0.41) ADRB3ADRB2ADRB1SMN1; SMN2MEN1
SCHEMBL8586756 0.80 ADRB3 (0.41) ADRB3ADRB2ADRB1SMN1; SMN2MEN1
SCHEMBL9063602 0.79 AOC3 (0.43) AOC3MEN1KMT2ACYP2B6IDO1
SCHEMBL7069969 0.78 ADRB3 (0.35) ADRB3ADRB2ADRB1GLAAOC3
SCHEMBL7003007 0.77 AOC3 (0.43) AOC3IDO1
SCHEMBL7716942 0.77 AOC3 (0.38) ADRB3ADRB2ADRB1GLAAOC3
SCHEMBL7716940 0.77 AOC3 (0.38) ADRB3ADRB2ADRB1GLAAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865421-B1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LTD (GB) 2002-03-27 EP disclosed
US-6048872-A DIETETICS; ANTIDIABETIC AGENTS; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS GLAXO WELLCOME INC. (US) 2000-04-11 US disclosed
EP-0865421-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1998-09-23 EP disclosed
WO-1997021665-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed
WO-1997021666-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed
WO-1995033724-A1 PHENETHANOLAMINE DERIVATIVES AND THEIR USE AS ATYPICAL BETA-ADRENOCEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1995-12-14 WO disclosed